Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate vs stiripentol vs high-dose clobazam adjunctive trial in pediatric Dravet syndrome
2007-002198-30Phase 3Terminated
- Sponsor
- Inserm
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Dravet syndrome comparing Stiripentol add-on arm, Topiramate add-on arm and Maximal tolerated clobazam control arm (3 arms). Primary endpoint: Primary efficacy endpoint. Started Jan 2012; status: terminated.
02
Drugs
stiripentoltopiramateclobazam
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on 2007-002198-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002198-30.